Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 09 May 2025 for Edwards Lifesciences Corp. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Steven R. Loranger: trading record in brief
Filings by Steven R. Loranger span 2 companies, the busiest being Edwards Lifesciences Corp and Xylem Inc. We count 9 filings; the first trade dates from 5 May 2021 and the latest from 9 May 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 9 May 2025: a share grant, in Edwards Lifesciences Corp. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Steven R. Loranger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
3,528 shares0Common StockSEC:0001225208-25-004954:0
5,739 shares@ US$45.3167100.0% of flowCommon StockSEC:0001225208-25-001751:0
3,055 shares0Common StockSEC:0001225208-24-005898:0
1,580 shares0Common StockSEC:0001562180-23-004395:0
2,803 shares0Common StockSEC:0001225208-23-005908:0
1,812 shares0Common StockSEC:0001209191-22-029334:0
2,300 shares0Common StockSEC:0001225208-22-006590:0
1,328 shares0Common StockSEC:0001209191-21-032357:0
2,615 shares0Common StockSEC:0001225208-21-007756:0
9 of 9 declarations
